ABSTRACT
Here, we report a de novo metal-catalyzed approach toward the stereoselective glycosidic bond formation in saccharomicin. The signature step is highlighted by the Pd-catalyzed asymmetric coupling of ene-alkoxyallenes and highly functionalized alcohol substrates. The reaction showed high chemo-, regio-, and ligand-driven diastereoselectivity. In combination with the ring-closing metathesis and late-stage functionalization, this method led to highly efficient synthesis of saccharosamine-rhamnose and rhamnose-fucose fragments.
Subject(s)
Fucose/chemical synthesis , Hexosamines/chemical synthesis , Rhamnose/chemistry , Catalysis , Fucose/chemistry , Hexosamines/chemistry , Molecular Structure , Palladium/chemistryABSTRACT
Glycoside hydrolases (GH) are a large family of hydrolytic enzymes found in all domains of life. As such, they control a plethora of normal and pathogenic biological functions. Thus, understanding selective inhibition of GH enzymes at the atomic level can lead to the identification of new classes of therapeutics. In these studies, we identified a 4-âº-glucoside of valienamine (8) as an inhibitor of Streptomyces coelicolor (Sco) GlgE1-V279S which belongs to the GH13 Carbohydrate Active EnZyme family. The results obtained from the dose-response experiments show that 8 at a concentration of 1000 µM reduced the enzyme activity of Sco GlgE1-V279S by 65%. The synthetic route to 8 and a closely related 4-âº-glucoside of validamine (7) was achieved starting from readily available D-maltose. A key step in the synthesis was a chelation-controlled addition of vinylmagnesium bromide to a maltose-derived enone intermediate. X-ray structures of both 7 and 8 in complex with Sco GlgE1-V279S were solved to resolutions of 1.75 and 1.83 Å, respectively. Structural analysis revealed the valienamine derivative 8 binds the enzyme in an E2 conformation for the cyclohexene fragment. Also, the cyclohexene fragment shows a new hydrogen-bonding contact from the pseudo-diaxial C(3)-OH to the catalytic nucleophile Asp 394 at the enzyme active site. Asp 394, in fact, forms a bidentate interaction with both the C(3)-OH and C(7)-OH of the inhibitor. In contrast, compound 7 disrupts the catalytic sidechain interaction network of Sco GlgE1-V279S via steric interactions resulting in a conformation change in Asp 394. These findings will have implications for the design other aminocarbasugar-based GH13-inhibitors and will be useful for identifying more potent and selective inhibitors.
Subject(s)
Bacterial Proteins/antagonists & inhibitors , Cyclohexenes/chemical synthesis , Glucosides/chemical synthesis , Glycoside Hydrolase Inhibitors/chemical synthesis , Glycoside Hydrolases/chemistry , Hexosamines/chemical synthesis , Streptomyces coelicolor/enzymology , Amino Acid Substitution , Amino Acids/chemistry , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Carbohydrate Conformation , Catalytic Domain , Crystallography, X-Ray , Cyclohexenes/pharmacology , Glucosides/pharmacology , Glycoside Hydrolase Inhibitors/pharmacology , Glycoside Hydrolases/genetics , Hexosamines/pharmacology , Maltose/chemistry , Models, Molecular , Mutation, Missense , Nuclear Magnetic Resonance, Biomolecular , Point Mutation , Stereoisomerism , Streptomyces coelicolor/geneticsABSTRACT
The introduction of glycosides bearing basic nitrogen is challenging using conventional Lewis acid-promoted pathways owing to competitive coordination of the amine to the Lewis acid promoter. Additionally, because many aminoglycosides lack a C2 substituent, diastereomeric mixtures of O-glycosides are often produced. Herein, we present a method for the synthesis of α- or ß- 2,3,6-trideoxy-3-amino- and 2,4,6-trideoxy-4-amino O-glycosides from a common precursor. Our strategy proceeds by the reductive lithiation of thiophenyl glycoside donors and trapping of the resulting anomeric anions with 2-methyltetrahydropyranyl peroxides. We apply this strategy to the synthesis of α- and ß-forosamine, pyrrolosamine, acosamine, and ristosamine derivatives using primary and secondary peroxides as electrophiles. α-Linked products are obtained in 60-96% yield and with >50:1 selectivity. ß-Linked products are obtained in 45-94% yield and with 1.7->50:1 stereoselectivity. Contrary to donors bearing an equatorial amine substituent, donors bearing an axial amine substituent favored ß-products at low temperatures. This work establishes a general strategy to synthesize O-glycosides bearing a basic nitrogen.
Subject(s)
Glycosides/chemical synthesis , Nitrogen/chemistry , Glycosides/chemistry , Hexosamines/chemical synthesis , Hexosamines/chemistry , Peroxides/chemistry , StereoisomerismABSTRACT
Glycans carry a vast range of functions in nature. Utilizing their properties and functions in form of polymers, coatings or glycan derivatives for various applications makes the synthesis of modified glycans crucial. Since amines are easy to modify for subsequent reactions, we investigated regioselective amination conditions of different saccharides. Amination reactions were performed according to Kochetkov and Likhoshertov and accelerated by microwave irradiation. We optimized the synthesis of glycosylamines for N-acetyl-d-galactosamine, d-lactose, d-glucuronic acid and l-(-)-fucose using the design of experiments (DoE) approach. DoE enables efficient optimization with limited number of experimental data. A DoE software generated a set of experiments where reaction temperature, concentration of carbohydrate, nature of aminating agent and solvent were investigated. We found that the synthesis of glycosylamines significantly depends on the nature of the carbohydrate and on the reaction temperature. There is strong indication that high temperatures are favored for the amination reaction.
Subject(s)
Hexosamines/chemistry , Hexosamines/chemical synthesis , Microwaves , Models, Chemical , Software , AminationABSTRACT
2,4-Diamino-2,4,6-trideoxyglucose (bacillosamine) is a monosaccharide found in many pathogenic bacteria, variation in the functionalities appended to the amino groups occurs depending on the species the sugar is derived from. We here report the first synthesis of bacillosamine synthons that allow for the incorporation of two different functionalities at the C-2-N-acetyl and C-4-amines. We have developed chemistry to assemble a set of conjugation ready Neisseria meningitidis C-2-N-acetyl bacillosamine saccharides, carrying either an acetyl or (R)- or (S)-glyceroyl at the C-4 amine. The glyceroyl bacillosamines have been further extended at the C-3-OH with an α-d-galactopyranose to provide structures that occur as post-translational modifications of N. meningitidis PilE proteins, which make up the bacterial pili.
Subject(s)
Hexosamines/chemical synthesis , Neisseria meningitidis/chemistry , Hexosamines/chemistry , Molecular StructureABSTRACT
Reported herein is the synthesis of a number of building blocks of 2-amino-2-deoxy-d-mannose from common d-glucose precursors.
Subject(s)
Glucose/chemistry , Hexosamines/chemical synthesis , Mannose/analogs & derivatives , Carbohydrate Sequence , Hexosamines/chemistry , Mannose/chemistryABSTRACT
ProTides comprise an important class of prodrugs currently marketed and developed as antiviral and anticancer therapies. The ProTide technology employs phosphate masking groups capable of providing more favorable druglike properties and an intracellular activation mechanism for enzyme-mediated release of a nucleoside monophosphate. Herein, we describe the application of phosphoramidate chemistry to 1,3,4-O-acetylated N-acetylmannosamine (Ac3ManNAc) to deliver ManNAc-6-phosphate (ManNAc-6-P), a critical intermediate in sialic acid biosynthesis. Sialic acid deficiency is a hallmark of GNE myopathy, a rare congenital disorder of glycosylation (CDG) caused by mutations in GNE that limit the production of ManNAc-6-P. Synthetic methods were developed to provide a library of Ac3ManNAc-6-phosphoramidates that were evaluated in a series of studies for their potential as a treatment for GNE myopathy. Prodrug 12b showed rapid activation in a carboxylesterase (CPY) enzymatic assay and favorable ADME properties, while also being more effective than ManNAc at increasing sialic acid levels in GNE-deficient cell lines. These results provide a potential platform to address substrate deficiencies in GNE myopathy and other CDGs.
Subject(s)
Distal Myopathies/drug therapy , Drug Delivery Systems , Hexosamines/pharmacology , Phosphotransferases (Alcohol Group Acceptor)/antagonists & inhibitors , Prodrugs/pharmacology , Sugar Phosphates/pharmacology , Animals , CHO Cells , Caco-2 Cells , Cell Survival/drug effects , Cells, Cultured , Cricetulus , Distal Myopathies/metabolism , Distal Myopathies/pathology , Dose-Response Relationship, Drug , Hexosamines/chemical synthesis , Hexosamines/chemistry , Humans , Molecular Structure , N-Acetylneuraminic Acid/analysis , Phosphotransferases (Alcohol Group Acceptor)/deficiency , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Prodrugs/chemical synthesis , Prodrugs/chemistry , Structure-Activity Relationship , Sugar Phosphates/chemical synthesis , Sugar Phosphates/chemistryABSTRACT
The isolation, characterization, and total synthesis of the macrocyclic polyene mangrolide D is reported. A 16-step total synthesis relies on robust Suzuki and ring-closing metathesis reactions, and an iron-catalyzed hydroazidation of an exomethylene substituted tetrahydropyran as a key step for the synthesis of the appended 4- epi-vancosamine sugar. Although mangrolide D did not display antibiotic activity, this work should prove enabling toward the synthesis of the antitubercular tiacumicins which display a virtually identical macrocyclic backbone.
Subject(s)
Anti-Bacterial Agents/chemistry , Macrolides/chemistry , Polyenes/chemistry , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Aquatic Organisms , Bacillus subtilis/drug effects , Catalysis , Cycloaddition Reaction , Glycosylation , Hexosamines/chemical synthesis , Macrolides/chemical synthesis , Macrolides/pharmacology , Polyenes/chemical synthesis , Polyenes/pharmacology , Pseudomonas aeruginosa/drug effects , StereoisomerismABSTRACT
Infectious diseases due to multidrug-resistant pathogens, particularly carbapenem-resistant Enterobacteriaceae (CREs), present a major and growing threat to human health and society, providing an urgent need for the development of improved potent antibiotics for their treatment. We describe the design and development of a new class of aminoglycoside antibiotics culminating in the discovery of propylamycin. Propylamycin is a 4'-deoxy-4'-alkyl paromomycin whose alkyl substituent conveys excellent activity against a broad spectrum of ESKAPE pathogens and other Gram-negative infections, including CREs, in the presence of numerous common resistance determinants, be they aminoglycoside modifying enzymes or rRNA methyl transferases. Importantly, propylamycin is demonstrated not to be susceptible to the action of the ArmA resistance determinant whose presence severely compromises the action of plazomicin and all other 4,6-disubstituted 2-deoxystreptamine aminoglycosides. The lack of susceptibility to ArmA, which is frequently encoded on the same plasmid as carbapenemase genes, ensures that propylamycin will not suffer from problems of cross-resistance when used in combination with carbapenems. Cell-free translation assays, quantitative ribosome footprinting, and X-ray crystallography support a model in which propylamycin functions by interference with bacterial protein synthesis. Cell-free translation assays with humanized bacterial ribosomes were used to optimize the selectivity of propylamycin, resulting in reduced ototoxicity in guinea pigs. In mouse thigh and septicemia models of Escherichia coli, propylamycin shows excellent efficacy, which is better than paromomycin. Overall, a simple novel deoxy alkyl modification of a readily available aminoglycoside antibiotic increases the inherent antibacterial activity, effectively combats multiple mechanisms of aminoglycoside resistance, and minimizes one of the major side effects of aminoglycoside therapy.
Subject(s)
Aminoglycosides/chemical synthesis , Aminoglycosides/pharmacology , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Drug Design , Drug Resistance, Bacterial/drug effects , Enterobacteriaceae/drug effects , Aminoglycosides/chemistry , Animals , Anti-Bacterial Agents/chemistry , Chemistry Techniques, Synthetic , Guinea Pigs , Hexosamines/chemical synthesis , Hexosamines/chemistry , Hexosamines/pharmacology , Hexosamines/toxicity , Mice , Microbial Sensitivity Tests , NIH 3T3 Cells , Structure-Activity RelationshipABSTRACT
The secondary cell wall polysaccharide (SCWP) of Bacillus anthracis plays a key role in the organization of the cell envelope of vegetative cells and is intimately involved in host-guest interactions. Genetic studies have indicated that it anchors S-layer and S-layer-associated proteins, which are involved in multiple vital biological functions, to the cell surface of B. anthracis. Phenotypic observations indicate that specific functional groups of the terminal unit of SCWP, including 4,6- O-pyruvyl ketal and acetyl esters, are important for binding of these proteins. These observations are based on genetic manipulations and have not been corroborated by direct binding studies. To address this issue, a synthetic strategy was developed that could provide a range of pyruvylated oligosaccharides derived from B. anthracis SCWP bearing base-labile acetyl esters and free amino groups. The resulting oligosaccharides were used in binding studies with a panel of S-layer and S-layer-associated proteins, which identified structural features of SCWP important for binding. A single pyruvylated ManNAc monosaccharide exhibited strong binding to all proteins, making it a promising structure for S-layer protein manipulation. The acetyl esters and free amine of SCWP did not significantly impact binding, and this observation is contrary to a proposed model in which SCWP acetylation is a prerequisite for association of some but not all S-layer and S-layer-associated proteins.
Subject(s)
Bacillus anthracis/chemistry , Bacterial Proteins/chemistry , Cell Wall/chemistry , Hexosamines/chemistry , Membrane Glycoproteins/chemistry , Acetylation , Bacterial Proteins/metabolism , Hexosamines/chemical synthesis , Hexosamines/metabolism , Membrane Glycoproteins/metabolism , Protein Array Analysis , Protein Binding , Protein Domains , Trisaccharides/chemical synthesis , Trisaccharides/chemistry , Trisaccharides/metabolismABSTRACT
The rise in antibiotic-resistant bacteria is causing worldwide concerns. The urgent need for new antibacterial drugs calls for new thinking and strategies to explore novel, narrow-spectrum, and pathogen-specific antibacterial targets. Legionaminic acid (Leg) and pseudaminic acid (Pse) are nonulosonic acid carbohydrates with structural similarity to eukaryotic sialic acid, and are distributed in numerous pathogenic Gram-negative bacteria as components of cell surface-associated glycans. They are involved in the host interaction, pathogenicity, antiphage defense mechanism, and immune escape mechanism. To further explore their biological significance, we developed a synthesis of 2-acetamido-4-azidoacetamido-2,4,6-trideoxy-l-altrose (Alt-4NAz) and 2-azidoacetamido-4-acetamido-2,4,6-trideoxy-l-altrose (Alt-2NAz), among which Alt-4NAz served as an effective chemical reporter to realize bacterial Pse metabolic labeling. The effectiveness of this chemical reporter has been demonstrated in Pseudomonas aeruginosa, Vibrio vulnificus, and Acinetobacter baumannii strains. Expectedly, this strategy can provide a useful assay to detect phenotypic presence of Pse biosynthesis and screen for agents targeting this pathway.
Subject(s)
Azides/metabolism , Hexosamines/metabolism , Polysaccharides, Bacterial/metabolism , Sugar Acids/metabolism , Acinetobacter baumannii/metabolism , Azides/chemical synthesis , Cell Membrane/metabolism , Click Chemistry , Fluorescence , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/chemistry , Fluorescent Dyes/metabolism , Glycosylation , Hexosamines/chemical synthesis , Lipopolysaccharides/biosynthesis , Lipopolysaccharides/chemistry , Pseudomonas aeruginosa/metabolism , Vibrio vulnificus/metabolismABSTRACT
In this study, we report incorporation of a covalent linker at the anomeric position of N-azidoacetylmannosamine (ManNAz) for caging its metabolic process. We synthesized a DT-diaphorase-responsive metabolic precursor, HQ-NN-AAM, using an optimized linker. The caged metabolite showed responsiveness to DT-diaphorase in vitro, resulting in metabolic incorporation of an azido sugar into the cell surface in multiple cell lines.
Subject(s)
Azides/metabolism , Cell Tracking/methods , Hexosamines/metabolism , NAD(P)H Dehydrogenase (Quinone)/metabolism , Polysaccharides/biosynthesis , Quinones/metabolism , Azides/chemical synthesis , Azides/chemistry , Cell Line, Tumor , Click Chemistry , Ethylenediamines/chemistry , Glycosylation , Hexosamines/chemical synthesis , Hexosamines/chemistry , Humans , Quinones/chemical synthesis , Quinones/chemistryABSTRACT
Unnatural chemically modified nucleotide sugars UDP-4-N3-GlcNAc and UDP-4-N3-GalNAc were chemically synthesized for the first time. These unnatural UDP sugar products were then tested for incorporation into hyaluronan, heparosan, or chondroitin using polysaccharide synthases. UDP-4-N3-GlcNAc served as a chain termination substrate for hyaluronan or heparosan synthases; the resulting 4-N3-GlcNAc-terminated hyaluronan and heparosan were then successfully conjugated with Alexa Fluor 488 DIBO alkyne, demonstrating that this approach is generally applicable for labeling and detection of suitable glycosaminoglycans.
Subject(s)
Glycosaminoglycans/analysis , Hexosamines/chemical synthesis , Uridine Diphosphate/chemical synthesis , Click Chemistry , Hexosamines/chemistry , Molecular Conformation , Uridine Diphosphate/chemistryABSTRACT
Valienamine and ß-valienamine are representative C7 N aminocyclitols with significant glycosidase inhibition activity that have been developed as important precursors of drugs for diabetes and lysosomal storage diseases, respectively. The quantitative analysis of these chiral compounds is crucial for asymmetric in vitro biosynthetic processes for converting valienone into valienamine epimers using aminotransferase. Here, we developed an efficient and sensitive method for separation and quantitative analysis of chiral valienamine using reversed-phase high-performance liquid chromatography (HPLC) through o-phthalaldehyde (OPA) pre-column derivatization of the analytes. The epimers were derivatized by OPA in borate buffer (pH 9.0) at room temperature for 30 s, separated on an Eclipse XDB-C18 (5 µm, 4.6 × 150 mm) column, eluted with 22% acetonitrile at 30 °C for 18 min, and detected by a fluorescence detector using 445 nm emission and 340 nm excitation wavelengths. The average resolution of the epimers is 3.86, and the concentration linearity is in the range of 0.02-20 µg/ml. The method proved to be effective, sensitive, and reliable with good intra- and inter-day precision and accuracy, and successfully evaluated the enantiopreference and catalytic capability of the potential aminotransferases on an unnatural prochiral substrate, facilitating the design of an asymmetric biosynthetic route for optically pure valienamine and ß-valienamine.
Subject(s)
Cyclohexenes/chemical synthesis , Hexosamines/chemical synthesis , o-Phthalaldehyde/chemistry , Catalysis , Chromatography, High Pressure Liquid/methods , Cyclohexenes/chemistry , Hexosamines/chemistry , Molecular Structure , StereoisomerismABSTRACT
The proprotein convertase furin is implicated in a variety of pathogenic processes such as bacterial toxin activation, viral propagation, and cancer. Several groups have identified non-peptide compounds with high inhibitory potency against furin in vitro, although their efficacy in various cell-based assays is largely unknown. In this study we show that certain guanidinylated 2,5-dideoxystreptamine derivatives exhibit interesting ex vivo properties. Compound 1b (1,1'-(4-((2,4-diguanidino-5-(4-guanidinophenoxy)cyclohexyl)oxy)-1,3-phenylene)diguanidine) is a potent and cell-permeable inhibitor of cellular furin, since it was able to retard tumor cell migration, block release of a Golgi reporter, and protect cells against Bacillus anthracis (anthrax) and Pseudomonas aeruginosa intoxication, with no evident cell toxicity. Other compounds based on the 2,5-dideoxystreptamine scaffold, such as compound 1g (1,1'-(4,6-bis(4-guanidinophenoxy)cyclohexane-1,3-diyl)diguanidine) also efficiently protected cells against anthrax, but displayed only moderate protection against Pseudomonas exotoxin A and did not inhibit cell migration, suggesting poor cell permeability. Certain bis-guanidinophenyl ether derivatives such as 2f (1,3-bis(2,4-diguanidinophenoxy) benzene) exhibited micromolar potency against furin in vitro, low cell toxicity, and highly efficient protection against anthrax toxin; this compound only slightly inhibited intracellular furin. Thus, compounds 1g and 2f both represent potent furin inhibitors at the cell surface with low intracellular inhibitory action, and these particular compounds might therefore be of preferred therapeutic interest in the treatment of certain bacterial and viral infections.
Subject(s)
Anti-Bacterial Agents/chemistry , Furin/antagonists & inhibitors , Guanidines/chemistry , Hexosamines/chemistry , Animals , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Bacillus anthracis/metabolism , Bacterial Toxins/pharmacology , Cell Line , Cell Membrane/enzymology , Cell Movement/drug effects , Cell Survival/drug effects , Cricetulus , Guanidines/chemical synthesis , Guanidines/pharmacology , Hexosamines/chemical synthesis , Hexosamines/pharmacology , Humans , Intracellular Space/enzymology , Mice , Models, Molecular , Pseudomonas aeruginosa/metabolism , Structure-Activity RelationshipABSTRACT
The osmium-catalyzed aminohydroxylation of glycals has been achieved with complete regio- and stereocontrol by taking advantage of the Donohoe tethering approach. Glucals and galactals showed complementary reactivity in dependence of the stage at which the reaction was performed, i.e., directly or after double-bond shift consequent to a Ferrier rearrangement (that is, on the 1,2 or 2,3-unsaturated sugar), allowing access to both classes of 2-amino (mannosamine) and 3-amino (talosamine) sugar derivatives, respectively.
Subject(s)
Amino Sugars/chemistry , Galactosides/chemical synthesis , Glycosides/chemical synthesis , Hexosamines/chemical synthesis , Osmium/chemistry , Carbohydrates/chemistry , Catalysis , Galactosides/chemistry , Glycosides/chemistry , Hexosamines/chemistry , Hydroxylation , Molecular Structure , StereoisomerismABSTRACT
UNLABELLED: The emerging epidemic of drug resistance places the development of efficacious and safe antibiotics in the spotlight of current research. Here, we report the design of next-generation aminoglycosides. Discovery efforts were driven by rational synthesis focusing on 4' alkylations of the aminoglycoside paromomycin, with the goal to alleviate the most severe and disabling side effect of aminoglycosides-irreversible hearing loss. Compounds were evaluated for target activity in in vitro ribosomal translation assays, antibacterial potency against selected pathogens, cytotoxicity against mammalian cells, and in vivo ototoxicity. The results of this study produced potent compounds with excellent selectivity at the ribosomal target, promising antibacterial activity, and little, if any, ototoxicity upon chronic administration. The favorable biocompatibility profile combined with the promising antibacterial activity emphasizes the potential of next-generation aminoglycosides in the treatment of infectious diseases without the risk of ototoxicity. IMPORTANCE: The ever-widening epidemic of multidrug-resistant infectious diseases and the paucity of novel antibacterial agents emerging from modern screening platforms mandate the reinvestigation of established drugs with an emphasis on improved biocompatibility and overcoming resistance mechanisms. Here, we describe the preparation and evaluation of derivatives of the established aminoglycoside antibiotic paromomycin that effectively remove its biggest deficiency, ototoxicity, and overcome certain bacterial resistance mechanisms.
Subject(s)
Aminoglycosides/pharmacology , Anti-Bacterial Agents/pharmacology , Aminoglycosides/chemical synthesis , Animals , Anti-Bacterial Agents/chemical synthesis , Bacterial Infections/drug therapy , Escherichia coli/drug effects , Guinea Pigs , Hexosamines/chemical synthesis , Hexosamines/pharmacology , Male , Mice , Mice, Inbred ICR , Microbial Sensitivity Tests , NIH 3T3 Cells , Phylogeny , RNA, Ribosomal, 16S/genetics , Ribosomes/drug effects , Staphylococcus aureus/drug effectsABSTRACT
A concise asymmetric synthesis of aminocyclitols, such as diastereomeric 2-deoxystreptamine analogues and conduramineâ A, is described. The Pd-catalyzed asymmetric desymmetrization of meso 1,4-dibenzolate enables the synthesis of highly oxidized cyclohexane architectures. These scaffolds can potentially be used to access new aminoglycoside antibiotics and enantiomerically pure α-glucosidase inhibitors.
Subject(s)
Cyclohexanols/chemistry , Cyclohexylamines/chemistry , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Catalysis , Cyclohexanes/chemistry , Cyclohexanols/chemical synthesis , Cyclohexylamines/chemical synthesis , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Glucosidases/antagonists & inhibitors , Glucosidases/metabolism , Hexosamines/chemical synthesis , Hexosamines/chemistry , Oxidation-Reduction , Palladium/chemistry , StereoisomerismABSTRACT
Total synthesis of the bacillosamine containing l-serine linked O-trisaccharide of Neisseria meningitidis is described. The synthesis entails installation of two consecutive α-linkages including the coupling of bacillosamine with l-serine derivative.
Subject(s)
Hexosamines/chemistry , Hexosamines/chemical synthesis , Neisseria meningitidis/chemistry , Serine/chemistry , Trisaccharides/chemistry , Molecular Conformation , Trisaccharides/chemical synthesisABSTRACT
Aminoglycoside-antibiotics represent important tools for studying the biological functions of RNA. An orthogonal protection strategy applied on 2-deoxystreptamine (2-DOS) revealed a series of key intermediates that enable its regioselective functionalization. Our approach allowed the construction of selected representatives of triazole-containing analogues with diverse molecular frameworks for biological evaluation regarding their binding and antibacterial potencies.